SYNTA PHARMACEUTICALS CORP - COM (SNTA)

CUSIP: 87162T206

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
36,180,716
Share change
-5,527,891
Total reported value
$9,412,000
Price per share
$0.26
Number of holders
46
Value change
-$1,438,728
Number of buys
17
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 87162T206?
CUSIP 87162T206 identifies SNTA - SYNTA PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q2 2016

As of 30 Jun 2016, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,180,716 shares. The largest 10 holders included CAXTON CORP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, BlackRock Institutional Trust Company, N.A., and Connor, Clark & Lunn Investment Management Ltd.. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.